BridgeBio Pharma (BBIO) Interest Coverage Ratio (QoQ) (2018 - 2026)
BridgeBio Pharma (BBIO) Interest Coverage Ratio (QoQ) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | BridgeBio Pharma | 16.15 Bn | 15.22 Bn | 184.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 56.52% |
| Dec 31, 2025 | -411.83% |
| Sep 30, 2025 | -258.24% |
| Jun 30, 2025 | 85.42% |
| Mar 31, 2025 | 56.60% |
| Dec 31, 2024 | -24.28% |
| Sep 30, 2024 | -213.15% |
| Jun 30, 2024 | -27,437.89% |
| Mar 31, 2024 | 100.17% |
| Dec 31, 2023 | 25.00% |
| Sep 30, 2023 | -9.47% |
| Jun 30, 2023 | -24.04% |
| Mar 31, 2023 | -45.44% |
| Dec 31, 2022 | 39.62% |
| Sep 30, 2022 | -64.73% |
| Jun 30, 2022 | 53.69% |
| Mar 31, 2022 | -16.78% |
| Dec 31, 2021 | -23.71% |
| Sep 30, 2021 | -563.68% |
| Jun 30, 2021 | 94.82% |